| 000 | 01826 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514224025.0 | ||
| 264 | 0 | _c20050830 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0306-4522 | ||
| 024 | 7 |
_a10.1016/j.neuroscience.2004.11.056 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohapel, P | |
| 245 | 0 | 0 |
_aPlatelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. _h[electronic resource] |
| 260 |
_bNeuroscience _c2005 |
||
| 300 |
_a767-76 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xadministration & dosage |
| 650 | 0 | 4 |
_aBromodeoxyuridine _xmetabolism |
| 650 | 0 | 4 |
_aCell Count _xmethods |
| 650 | 0 | 4 |
_aCorpus Striatum _xcytology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDoublecortin Protein |
| 650 | 0 | 4 | _aDrug Administration Routes |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 |
_aMicroscopy, Confocal _xmethods |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aParkinson Disease _xetiology |
| 650 | 0 | 4 |
_aPlatelet-Derived Growth Factor _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aFrielingsdorf, H | |
| 700 | 1 | _aHäggblad, J | |
| 700 | 1 | _aZachrisson, O | |
| 700 | 1 | _aBrundin, P | |
| 773 | 0 |
_tNeuroscience _gvol. 132 _gno. 3 _gp. 767-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2004.11.056 _zAvailable from publisher's website |
| 999 |
_c15505391 _d15505391 |
||